Organ-on-chip technology refers to microfluidic devices that mimic the structure and function of human organs. These chips can be used to model various physiological processes and diseases.
It addresses the limitations of traditional drug testing methods, which often fail to predict human responses due to species differences or lack of complexity. Organ-on-chip technology provides a more accurate and ethical alternative by closely mimicking human physiology.
These chips are fabricated using microfabrication techniques, often involving layers of flexible or rigid materials like polymers or silicon. They contain channels where cells from a specific organ type are cultured, along with microfluidic systems that mimic the blood flow and other physiological conditions found in vivo. By integrating multiple organs on one chip, researchers can study complex interactions between different organ systems.
Manufacturing involves precise microfabrication techniques such as soft lithography, photolithography, and etching processes. Materials like polydimethylsiloxane (PDMS), polymers, and metals are commonly used.
The process typically starts with designing the chip layout using CAD software. Then, materials are deposited or molded into the desired shape. Cells from human donors or induced pluripotent stem cells are then cultured within the microchannels to create a functional organ model.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.